1 |
Li, J. W., and Vederas, J. C. (2009). Drug discovery and natural products: end of an era or an endless frontier? Science 325, 161-165.
DOI
ScienceOn
|
2 |
Lehar, J., Krueger, A. S., Avery, W., Heilbut, A. M., Johansen, L. M., Price, E. R., Rickles, R. J., Short, G. F., 3rd, Staunton, J. E., Jin, X., et al. (2009). Synergistic drug combinations tend to improve therapeutically relevant selectivity. Nat Biotechnol 27, 659-666.
DOI
ScienceOn
|
3 |
Zhao, X. M., Iskar, M., Zeller, G., Kuhn, M., van Noort, V., and Bork, P. (2011). Prediction of drug combinations by integrating molecular and pharmacological data. PLoS Comput Biol 7, e1002323.
DOI
|
4 |
Zhang, B. B., Zhou, G., and Li, C. (2009). AMPK: an emerging drug target for diabetes and the metabolic syndrome. Cell Metab 9, 407-416.
DOI
ScienceOn
|
5 |
Robert, C., Green, M. (2005). Diagnosis and Management of Alzheimer's Disease and Other Dementias. 2 Edition.: Professional Communications.
|
6 |
Chang, R. L., Xie, L., Bourne, P. E., and Palsson, B. O. (2010). Drug offtarget effects predicted using structural analysis in the context of a metabolic network model. PLoS Comput Biol 6, e1000938.
DOI
ScienceOn
|
7 |
Folger, O., Jerby, L., Frezza, C., Gottlieb, E., Ruppin, E., and Shlomi, T. (2011). Predicting selective drug targets in cancer through metabolic networks. Mol Syst Biol 7, 501.
|
8 |
Gottlieb, A., Stein, G. Y., Oron, Y., Ruppin, E., and Sharan, R. (2012). INDI: a computational framework for inferring drug interactions and their associated recommendations. Mol Syst Biol 8, 592.
|
9 |
Bibi, Z. (2008). Role of cytochrome P450 in drug interactions. Nutr Metab (Lond) 5, 27.
DOI
ScienceOn
|
10 |
Barabasi, A. L., and Oltvai, Z. N. (2004). Network biology: understanding the cell's functional organization. Nat Rev Genet 5, 101-113.
DOI
ScienceOn
|
11 |
Zimmermann, G. R., Lehár, J., and Keith, C. T. (2007). Multi-target therapeutics: when the whole is greater than the sum of the parts. Drug Discov Today 12, 34-42.
DOI
ScienceOn
|
12 |
Vander Heiden, M. G. (2011). Targeting cancer metabolism: a therapeutic window opens. Nat Rev Drug Discov 10, 671-684.
DOI
ScienceOn
|
13 |
Chong, Z. Z., Wang, S., Shang, Y. C., and Maiese, K. (2012). Targeting cardiovascular disease with novel SIRT1 pathways. Future Cardiol 8, 89-100.
DOI
|
14 |
Huang, J., Niu, C., Green, C. D., Yang, L., Mei, H., and Han, J. D. (2013). Systematic Prediction of Pharmacodynamic Drug-Drug Interactions through Protein-Protein-Interaction Network. PLoS Comput Biol 9, e1002998.
DOI
|
15 |
Liu, Y., Hu, B., Fu, C., and Chen, X. (2010). DCDB: drug combination database. Bioinformatics 26, 587-588.
DOI
ScienceOn
|
16 |
Jia, J., Zhu, F., Ma, X., Cao, Z., Li, Y., and Chen, Y. Z. (2009). Mechanisms of drug combinations: interaction and network perspectives. Nat Rev Drug Discov 8, 111-128.
DOI
ScienceOn
|
17 |
Mathivanan, S., Ahmed, M., Ahn, N. G., Alexandre, H., Amanchy, R., Andrews, P. C., Bader, J. S., Balgley, B. M., Bantscheff, M., Bennett, K. L., et al. (2008). Human Proteinpedia enables sharing of human protein data. Nat Biotechnol 26, 164-167.
DOI
ScienceOn
|
18 |
Duarte, N. C., Becker, S. A., Jamshidi, N., Thiele, I., Mo, M. L., Vo, T. D., Srivas, R., and Palsson, B. O. (2007). Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc Natl Acad Sci U S A 104, 1777-1782.
DOI
ScienceOn
|
19 |
Wolfram Research, I. (2010). Mathematica Edition: Version 8.0. Champaign, Illinois: Wolfram Research, Inc.
|
20 |
Ashburn, T. T., and Thor, K. B. (2004). Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov 3, 673-683.
DOI
ScienceOn
|